Molekulargenetisches Labor
Zentrum für Nephrologie und Stoffwechsel
Moldiag Erkrankungen Gene Support Kontakt

Essentieller NF-kappa-B-Modulator

Das IKBKG-Gen kodiert ein Modulator der NF-kappa-B-Funktion. Mutationen führen zu x-chromosomal dominanten oder rezessiven Störungen des Ektoderms und der Immunabwehr.

Gentests:

Klinisch Untersuchungsmethoden Familienuntersuchung
Bearbeitungszeit 5 Tage
Probentyp genomische DNS
Klinisch Untersuchungsmethoden Hochdurchsatz-Sequenzierung
Bearbeitungszeit 25 Tage
Probentyp genomische DNS
Forschung Untersuchungsmethoden Direkte Sequenzierung der proteinkodierenden Bereiche eines Gens
Bearbeitungszeit 25 Tage
Probentyp genomische DNS
Forschung Untersuchungsmethoden Multiplex ligationsabhängige Amplifikation
Bearbeitungszeit 25 Tage
Probentyp genomische DNS

Verknüpfte Erkrankungen:

Ektodermale Dysplasie mit Immundefekt 1
IKBKG
Ektodermale Dysplasie-Immundefekt-Anhidrose-Lymphödem-Syndrom
IKBKG
Immundefekt 33
IKBKG
X-chromosomale Suszeptibilität für Mykobakteriosen durch IKBKG-Defekt
IKBKG
Incontinentia pigmenti
IKBKG
Invasive Pneumokokken-Erkrankung 2
IKBKG

Referenzen:

1.

Ku CL et al. (2007) IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease.

external link
2.

Kovalenko A et al. (2003) The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination.

external link
3.

Nishikomori R et al. (2004) X-linked ectodermal dysplasia and immunodeficiency caused by reversion mosaicism of NEMO reveals a critical role for NEMO in human T-cell development and/or survival.

external link
4.

Fusco F et al. (2004) Molecular analysis of the genetic defect in a large cohort of IP patients and identification of novel NEMO mutations interfering with NF-kappaB activation.

external link
5.

Orange JS et al. (2004) Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia.

external link
6.

Niehues T et al. (2004) Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia.

external link
7.

Jain A et al. (2004) Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation.

external link
8.

Martinez-Pomar N et al. (2005) A new mutation in exon 7 of NEMO gene: late skewed X-chromosome inactivation in an incontinentia pigmenti female patient with immunodeficiency.

external link
9.

Ørstavik KH et al. (2006) Novel splicing mutation in the NEMO (IKK-gamma) gene with severe immunodeficiency and heterogeneity of X-chromosome inactivation.

external link
10.

Vinolo E et al. (2006) A point mutation in NEMO associated with anhidrotic ectodermal dysplasia with immunodeficiency pathology results in destabilization of the oligomer and reduces lipopolysaccharide- and tumor necrosis factor-mediated NF-kappa B activation.

external link
11.

Wu ZH et al. (2006) Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli.

external link
12.

Puel A et al. (2006) The NEMO mutation creating the most-upstream premature stop codon is hypomorphic because of a reinitiation of translation.

external link
13.

Filipe-Santos O et al. (2006) X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production.

external link
14.

Brummelkamp TR et al. (2003) Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB.

external link
15.

Nenci A et. al. (2007) Epithelial NEMO links innate immunity to chronic intestinal inflammation.

external link
16.

Singh A et al. (2009) Impaired priming and activation of the neutrophil NADPH oxidase in patients with IRAK4 or NEMO deficiency.

external link
17.

Siggs OM et al. (2010) A mutation of Ikbkg causes immune deficiency without impairing degradation of IkappaB alpha.

external link
18.

Takada H et al. (2010) NEMO mutation as a cause of familial occurrence of Behçet's disease in female patients.

external link
19.

Gautheron J et al. (2010) Identification of a new NEMO/TRAF6 interface affected in incontinentia pigmenti pathology.

external link
20.

Gerlach B et al. (2011) Linear ubiquitination prevents inflammation and regulates immune signalling.

external link
21.

Tokunaga F et al. (2011) SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex.

external link
22.

Ikeda F et al. (2011) SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis.

external link
23.

Chiu JC et al. (2011) NEMO/NLK phosphorylates PERIOD to initiate a time-delay phosphorylation circuit that sets circadian clock speed.

external link
24.

Fusco F et al. (2012) Genomic architecture at the Incontinentia Pigmenti locus favours de novo pathological alleles through different mechanisms.

external link
25.

Boisson B et al. (2019) Rescue of recurrent deep intronic mutation underlying cell type-dependent quantitative NEMO deficiency.

external link
26.

May MJ et al. (2000) Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex.

external link
27.

de Jesus AA et al. (2020) Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases.

external link
28.

Lie SO et al. (1978) Transient B cell immaturity with intractable diarrhoea: a possible new immunodeficiency syndrome.

external link
29.

Roberts JL et al. (1998) Incontinentia pigmenti in a newborn male infant with DNA confirmation.

external link
30.

Yamaoka S et al. (1998) Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation.

external link
31.

Rothwarf DM et al. (1998) IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex.

external link
32.

Li Y et al. (1999) Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis.

external link
33.

Jin DY et al. () Isolation of full-length cDNA and chromosomal localization of human NF-kappaB modulator NEMO to Xq28.

external link
34.

Li Q et al. (1999) Severe liver degeneration in mice lacking the IkappaB kinase 2 gene.

external link
35.

Rudolph D et al. (2000) Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice.

external link
36.

Smahi A et al. (2000) Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.

external link
37.

Makris C et al. (2000) Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti.

external link
38.

Schmidt-Supprian M et al. (2000) NEMO/IKK gamma-deficient mice model incontinentia pigmenti.

external link
39.

Matsuzawa A et al. (2008) Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex.

external link
40.

Zonana J et al. (2000) A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO).

external link
41.

Aradhya S et al. (2001) Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma).

external link
42.

Jain A et al. (2001) Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia.

external link
43.

Döffinger R et al. (2001) X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling.

external link
44.

Kosaki K et al. (2001) Female patient showing hypohidrotic ectodermal dysplasia and immunodeficiency (HED-ID).

external link
45.

Aradhya S et al. (2001) A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations.

external link
46.

Kenwrick S et al. (2001) Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome.

external link
47.

Aradhya S et al. (2001) Multiple pathogenic and benign genomic rearrangements occur at a 35 kb duplication involving the NEMO and LAGE2 genes.

external link
48.

Orange JS et al. (2002) Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations.

external link
49.

None (2002) Pushing the limits of the scanning mechanism for initiation of translation.

external link
50.

Bardaro T et al. (2003) Two cases of misinterpretation of molecular results in incontinentia pigmenti, and a PCR-based method to discriminate NEMO/IKKgamma dene deletion.

external link
Update: 14. August 2020
Copyright © 2005-2020 Zentrum für Nephrologie und Stoffwechsel, Dr. Mato Nagel
Albert-Schweitzer-Ring 32, D-02943 Weißwasser, Deutschland, Tel.: +49-3576-287922, Fax: +49-3576-287944
Seitenüberblick | Webmail | Haftungsausschluss | Datenschutz